Cambridge Cognition Holdings Plc (AIM: COG)
London
· Delayed Price · Currency is GBP · Price in GBX 42.34
+0.34 (0.80%)
Jan 22, 2025, 9:12 AM GMT+1
AIM: COG Revenue
Cambridge Cognition Holdings had revenue of 5.60M GBP in the half year ending June 30, 2024, a decrease of -4.69%. This brings the company's revenue in the last twelve months to 13.08M, up 2.40% year-over-year. In the year 2023, Cambridge Cognition Holdings had annual revenue of 13.52M with 7.15% growth.
Revenue (ttm)
13.08M
Revenue Growth
+2.40%
P/S Ratio
1.13
Revenue / Employee
109.91K
Employees
119
Market Cap
17.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 13.52M | 902.00K | 7.15% |
| Dec 31, 2022 | 12.61M | 2.52M | 24.96% |
| Dec 31, 2021 | 10.09M | 3.35M | 49.74% |
| Dec 31, 2020 | 6.74M | 1.70M | 33.70% |
| Dec 31, 2019 | 5.04M | -1.09M | -17.80% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Cambridge Cognition Holdings News
- 4 months ago - Small Cap Stocks: Quantum Blockchain, Arkle Resources, Chariot O&G - The Armchair Trader